Stock Rating Upgrade
The Value Trend Rating for Resmed Inc (NYSE: RMD) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Resmed Inc (NYSE: RMD) stock closed at $219.70 on 3/21/25 after a slight decline of -0.6%. NORMAL trading volume accompanied the decline. The stock is unchanged during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Resmed has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Resmed has a poor Appreciation Score of 26 but a slightly positive Power Rating of 61, triggering the Low Neutral Value Trend Rating.
Be the first to comment